The diagnosis of growth hormone deficiency (GHD) in successfully treated acromegalic patients
The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
Due to persistent qualitative abnormali‐ties in GH secretion following treatment, and lack of a sensitive marker of GHD in mid‐adult life it is extremely difficult to diagnose GHD in treated acromegalic patients. The diagnosis of GHD in patients with pituitary disease relies on provocative tests of GH reserve. Arginine releases GH by reducing somatostatin inhibition of GH release, whereas GH secretagogues (GHS) affect GH release by direct stimulation of the GHS receptor, though an intact GH releasing hormone (GHRH) axis is a prerequisite. The peak GH response to insulin‐induced hypoglycaemia and arginine in acromegalic patients, in whom basal serum GH levels of less than 5 mU/l have been achieved, is greatly diminished in those treated by hypothalamo–pituitary irradiation. We aimed to study the response of successfully treated acromegalic patients to the growth hormone secretagogue hexarelin in view of its different putative mechanism of action, and in addition, to determine whether it has any value in the diagnosis of GH deficiency in this subset of patients. Nineteen acromegalic patients, in whom mean serum GH levels below 5 mU/l have been achieved through treatment, were recruited. Eight of the patients had been treated by surgery alone (Group A) and 11 had received primary or postoperative irradiation (Group B). All patients underwent 20 min blood sampling to provide a 24‐h GH profile. Serum IGF‐I was measured from a sample drawn between 0900 h and 1000 h. On a second visit arginine 20 g/m 2 was infused over 30 min, blood samples were taken before commencing the infusion and at 30‐min intervals thereafter for 180 min. At the final visit hexarelin 1·5 mcg/kg was administered as an intravenous bolus at t = 0. Blood was drawn at 15‐min intervals from − 30 to 180 min. All patients in group A showed an increment in serum GH following hexarelin (ΔGH HEX) > 20 mU/l, a normal response to arginine, and a mean 24‐h GH > 0·5 mU/l. In group B only 4/11 achieved a ΔGH HEX > 20 mU/l, 5/11 producing a response of < 2 mU/l. Four of the five patients with a ΔGH HEX < 2 mU/l were also demonstrated to have a mean 24‐h GH of < 0·5 mU/l and serum IGF‐I SDS < + 0·5. All four patients in Group B who achieved a ΔGH HEX > 20 mU/l, were observed to show an absent or minimal GH response to arginine. Despite loss of the GH response to arginine, the ΔGH HEX is retained in a proportion of those patients in whom ‘safe’ GH levels were achieved following irradiation. From the putative mechanisms of action of these provocative agents a plausible explanation would be that the GHRH axis is more resilient than endogenous somatostatin‐secreting neurones to radiation‐induced damage. Furthermore, GH secretagogues may have a role, in combination with serum IGF‐I levels, in the diagnosis of GH deficiency in treated acromegaly.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Premature mortality due to cardiovascular disease in hypopituitarism
Rosén, T., & Bengtsson, B.-Å. (1990) · The Lancet · doi:10.1016/0140-6736(90)91812-o · Cited by 1,402
Salomon, F., Cuneo, R. C., Hesp, R., & Sönksen, P. H. (1989) · New England Journal of Medicine · doi:10.1056/nejm198912283212605 · Cited by 1,326
Growth hormone deficiency in adulthood and the effects of growth hormone replacement: a review
Carroll, P. V., Christ the members of Growth Hormon, E. R., Bengtsson, B. Å., Carlsson, L., Christiansen, J. S., Clemmons, D., Hintz, R., Ho, K., Laron, Z., Sizonenko, P., et al. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.2.4594 · Cited by 822 · cited 1×
“Fax: 1 44 (0)161 4463772. arterial atherosclerotic changes (Caidahl et al., 1994; Salomon et al., 1989; Johansson et al., 1996; Carroll et al., 1998; Pfeifer et al., 1999).”
Self-citationThe Diagnosis of Growth Hormone Deficiency in Children and Adults
Shalet, S. M., Toogood, A., Rahim, A., & Brennan, B. M. D. (1998) · Endocrine Reviews · doi:10.1210/edrv.19.2.0329 · Cited by 414
Self-citationDiagnosis of growth-hormone deficiency in adults
Hoffman, D. M., O'Sullivan, A. J., Ho, K. K. Y., & Baxter, R. C. (1994) · The Lancet · doi:10.1016/s0140-6736(94)90181-3 · Cited by 386
New approach to the diagnosis of growth hormone deficiency in adults
Ghigo, E., Aimaretti, G., Gianotti, L., Bellone, J., Arvat, E., & Camanni, F. (1996) · European Journal of Endocrinology · doi:10.1530/eje.0.1340352 · Cited by 257 · cited 2×
“When severely GHD adults are stratified for the age ranges 20±40, 41±60 and 61±80 years, serum IGF-I is below the normal range (2 2 ́0 to 1 2 ́0 SDS) in 91 ́4%, 50 ́0% and 7 ́7%, respectively (Ghigo et al., 1996).”
Background
Cited by
(2011) · Endocrine Practice · doi:10.4158/ep.17.s4.1 · Cited by 259
Miller, K. K., Wexler, T., Fazeli, P., Gunnell, L., Graham, G. J., Beauregard, C., Hemphill, L., Nachtigall, L., Loeffler, J., Swearingen, B., et al. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-1611 · Cited by 66
Growth hormone deficiency in treated acromegaly
Mazziotti, G., Marzullo, P., Doga, M., Aimaretti, G., & Giustina, A. (2015) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2014.10.005 · Cited by 33
Tritos, N. A., Johannsson, G., Korbonits, M., Miller, K. K., Feldt-Rasmussen, U., Yuen, K. C. J., King, D., Mattsson, A. F., Jonsson, P. J., Koltowska-Haggstrom, M., et al. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-1013 · Cited by 31
The accuracy of diagnostic tests for GH deficiency in adults: a systematic review and meta-analysis
Hazem, A., Elamin, M. B., Malaga, G., Bancos, I., Prevost, Y., Zeballos-Palacios, C., Velasquez, E. R., Erwin, P. J., Natt, N., Montori, V. M., et al. (2011) · European Journal of Endocrinology · doi:10.1530/eje-11-0476 · Cited by 16
Metadata
- Authors
- Murray, R. D., Peacey, S. R., Rahim, A., Toogood, A. A., Thorner, M. O., & Shalet, S. M.
- Venue
- Clinical Endocrinology
- Publisher
- Wiley
- Published
- 2001-01
- Volume
- 54
- Issue
- 1
- Pages
- 37-44
- ISSN
- 0300-0664 (ISSN-L)
- 1365-2265
- OpenAlex
- W2077055541
- Cited by
- 29
- References
- 6
- FWCI
- 1.24
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The diagnosis of growth hormone deficiency (GHD) in successfully treated acromegalic patients. https://app.cochat.ai/papers/10.1046/j.1365-2265.2001.01189.x
- The paper
- Murray, R. D., Peacey, S. R., Rahim, A., Toogood, A. A., Thorner, M. O., & Shalet, S. M. (2001). The diagnosis of growth hormone deficiency (GHD) in successfully treated acromegalic patients. Clinical Endocrinology. https://doi.org/10.1046/j.1365-2265.2001.01189.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.